Rosemary Lynch

Dr. Rosemary Lynch

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
HLHannes Ludewig
Hannes Ludewig
SMSamuel Molyneux
Samuel Molyneux
SFScarlet Apollinaire Ferrinho
Scarlet Apollinaire Ferrinho
KGKai Guo
Kai Guo
RLRosemary Lynch
Rosemary Lynch
RGRebecca Goss
Rebecca Goss

29 May 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
AOAlan M. C. Obled
Alan M. C. Obled
RHRefaat B. Hamed
Refaat B. Hamed
ESEdward Spence
Edward Spence
MZMarija Ksenija Zacharova
Marija Ksenija Zacharova
SSSunil Sharma
Sunil Sharma
RGRebecca Goss
Rebecca Goss
The Bacillus horneckiae-like strain 2011SOCCUF3 was isolated from the marine sponge Spongia officinalis and its metabolome was studied for secondary metabolites with antimicrobial activity. Culturing in the presence of Diaion HP-20 resin and purifying the culture extract identified cyclo-phenylalanine-proline (cyclo-(Phe-Pro)), a 2,5-diketopiperazine (2,5-DKP), isolated as a major metabolite. Further, LCMS analysis of the extract showed the presence of two isomers of the molecule in the culture broth. To confirm the stereochemistry of the isomers observed in the natural extract, all four stereoisomers of cyclo-(Phe-Pro) were synthesised. NMR and LCMS studies identified the presence of both cis- and trans-cyclo-(Phe-Pro) isomers. Stability and epimerisation studies on synthetic isomers and the effect of culturing conditions suggested that the less stable cis isomer was naturally produced, which epimerised in culture broth.

19 June 2025 in Biomolecules
Verified
Journal Article
Open access
KMKevin P. P. Mahoney
Kevin P. P. Mahoney
RLRosemary Lynch
Rosemary Lynch
RBRhea T. Bown
Rhea T. Bown
SSSunil Sharma
Sunil Sharma
PCPiyasiri Chueakwon
Piyasiri Chueakwon
RGRebecca Goss
Rebecca Goss
Pharmaceuticals, such as the antibiotic erythromycin, and sodium-dependent glucose transporter (SGLT1 & SGTL2) inhibitors such as Bexagliflozin (diabetes) and Sotagliflozin (heart disease), are often sugar-decorated (glycosylated). Glycosylation is a key component of the binding motif in SGLT inhibitors and, in natural products, glycosylation often confers improved bioactivity and bioavailability. Whilst a single C-glycoside link between a sugar moiety and its aglycone core is a common feature in natural products isolated to date, only a small number, including the antibiotics granaticin and sarubicin, are covalently bonded twice to a single sugar moiety. The way in which this “double C-glycosylation” is naturally mediated is not yet known, yet has been speculated on. Here, we report the exploration and development of a potentially biomimetic procedure that utilises intermolecular cycloaddition chemistry to access new “double C-glycosylated” products and enables the creation of bridged polycyclic ethers from a common maltol-derived oxidopyrylium salt precursor.